02Jan 2018

STUDY OF COMPARISON OF LIVER FUNCTION TESTS IN DIABETES CASES AND NON-DIABETICS CONTROLS.

  • Senior Professor & Head, Department of Biochemistry, Govt. Medical College,Kota.
  • Final year PG resident, Department of Biochemistry, Govt. Medical College,Kota.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: diabetes is a metabolic disorder characterized by increased levels of blood glucose due to impairment in insulin action and/or insulin secretion. Liver plays a major role in the regulation of carbohydrate metabolism. It uses glucose as a fuel, store glucose as glycogen; also synthesize glucose from non-carbohydrate sources. Therefore, liver is more susceptible to diseases. Materials and methods: the study comprises of 100 subjects, out of whom 50 were diabetic cases and 50 non-diabetic control subjects. The subjects were those attending outdoor and indoor in New Medical College Hospital Kota, Rajasthan, India. Liver function test estimation by various methods mentioned above on fully automatic analyzer.Quantitative data was summarized in the form of mean ? sd and differences in means of both the groups were analyzed by unpaired student?t? test using graph pad prism.P-value less than 0.05 were considered significant. Results: the mean activity of serum bilirubin total (1.74 ? 0.897), bilirubin direct (0.474 ? 0.264), serum ast (62.56 ? 39.84 iu/l), serum alt (49.38 ? 45.85 u/l) and serum alp (134.32 ? 67.7 iu/l) of diabetic patients shows significant difference from that of normal subjects. Conclusion: the outcome of the present study shows that liver enzymes have higher activity in dm patients than controls. Thus screening for liver dysfunction in diabetics and subsequent workup may lead to early detection of hepatic co-morbidities and better management.


  1. Joshi SR, Parikh RM. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323?4. [PubMed]
  2. Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524?31. [PMC free article][PubMed]
  3. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369:1823?31. [PubMed]
  4. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, H?kkinen AM, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: Implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47:1360?9. [PubMed]
  5. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22:437?43. [PubMed]
  6. Tilg, H. et al. (2016) NAFLD and diabetes mellitus. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2016.147.

[Gulab Kanwar and Neeraj Saxena. (2018); STUDY OF COMPARISON OF LIVER FUNCTION TESTS IN DIABETES CASES AND NON-DIABETICS CONTROLS. Int. J. of Adv. Res. 6 (Jan). 66-69] (ISSN 2320-5407). www.journalijar.com


Dr. NEERAJ SAXENA
P.G. resident, G.M.C. KOTA

DOI:


Article DOI: 10.21474/IJAR01/6186      
DOI URL: http://dx.doi.org/10.21474/IJAR01/6186